4 Bio Readouts To Watch This Qtr

1. $Annovis Bio(ANVS.US)$
• Ph 3 data (also Ph 2/3 in AD).
• Buntanetap for Parkinson’s Disease.
• Exp Jan '24 but delayed (est this qtr).

2. $Axsome Therapeutics(AXSM.US)$
• Ph 3 data (SYMPHONY).
• AXS-12 for Narcolepsy.
• AXS-12 has Orphan Drug Designation.

3. $G1 Therapeutics(GTHX.US)$
• Ph 3 Overall Survival (OS) data.
• Trilaciclib (combo) for breast cancer (mTNBC).
• DMC recommended continuation earlier in Feb.

4. $Crinetics(CRNX.US)$
• Ph 3 data (PATHFNDR-2).
• Paltusotine for Acromegaly.
• PATHFNDR-1 data read out (+) in Q4 '23.